Savill P. Aspirin not warranted for primary prevention. Practitioner 2012;256 (1749):8

Aspirin not warranted for primary prevention

21 Mar 2012Registered users

The potential cardiovascular benefits of aspirin are outweighed by the risk of nontrivial bleeding in people without cardiovascular disease (CVD), a meta-analysis has shown. The researchers analysed nine randomised placebo-controlled trials reporting on cardiovascular disease, non-vascular outcomes or death.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.